Survival of dogs following surgical excision of histologically well-differentiated melanocytic neoplasms of the mucous membranes of the lips and oral cavity

Veterinary Pathology

Volumn 45, Issue 6, 2008, Pages 889-896

  Esplin, D G ^a  

^a ARUP LABORATORIES   (United States)

Author keywords

Canine; Lips; Melanocytic neoplasms; Oral cavity

Indexed keywords

CANIS FAMILIARIS;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; LIP TUMOR; MELANOMA; MORTALITY; MOUTH TUMOR; RETROSPECTIVE STUDY;

ANIMALS; DOG DISEASES; DOGS; LIP NEOPLASMS; MELANOMA; MOUTH NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 58149216757     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1354/vp.45-6-889     Document Type: Article

References (35)

1. Alexander AN, Huelsmeyer MK, Mitzey A, Dubiel-zig RR, Kurzman ID, MacEwen EG, Vail DM: Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma. Cancer Immunol Immunother 55:433-442, 2005
2. Bateman KE, Catton PA, Pennock PW, Kruth SA: 0-7-21 radiation therapy for the treatment of canine oral melanoma. J Vet Intern Med 8:267-272, 1994
3. Bergman PJ, Camps-Palau MA, McKnight JA, Leibman NF, Craft DM, Leung C, Liao J, Riviere I, Sadelain M, Hohenhaus AE, Gregor P, Houghton AN, Perales MA, Wolchok JD: Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine 24:4582-4585, 2006
4. Bergman PJ, McKnight J, Novosad A, Charney S, Farrelly J, Craft D, Wulderk M, Jeffers Y, Sadelain M, Hohenhaus AE, Segal N, Gregor P, Engelhorn M, Riviere I, Houghton AN, Wolchok JD: Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase. Clin Cancer Res 9:1284-1290, 2003
5. Blackwood L, Dobson JM: Radiotherapy of oral malignant melanomas in dogs. J Am Vet Med Assoc 209:98-102, 1996
6. Bolon B, Calderwood Mays MB, Hall BJ: Characteristics of canine melanomas and comparison of histology and DNA ploidy to their biologic behavior. Vet Pathol 27:96-102, 1990
7. Bostock DE: Prognosis after surgical excision of canine melanomas. Vet Pathol 16:32-40, 1979
8. Brodey RS: A clinical and pathologic study of 130 neoplasms of the mouth and pharynx in the dog. Am J Vet Res 21:787-812, 1960
9. Dennis MM, Ehrhart N, Duncan CG, Barnes AB, Ehrhart EJ: Frequency of and risk factors associated with lingual lesions in dogs: 1,196 cases (1995-2004). J Am Vet Med Assoc 228:1533-1537, 2006
10. Dorn RC, Priester WA: Epidemiologic analysis of oral and pharyngeal cancer in dogs, cats, horses, and cattle. J Am Vet Med Assoc 169:1202-1206, 1976
11. Dow SW, Elmslie RE, Willson AP, Roche L, Gorman C, Potter TA: In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma. J Clin Invest 101:2406-2414, 1998
12. Esplin DG: Biologic behavior of well-differentiated melanocytic neoplasms of the mucous membranes of the lips and oral cavity of dogs. Proceedings from the ACVP/ASVCP annual meeting, p. 300. American College of Veterinary Pathologists, Middleton, WI. [Abstract] 2002
13. Goldschmidt MH, Dunstan RW, Stannard AA, von Tscharner C, Walder EJ, Yager JA: Histological classification of epithelial and melanocytic tumors of the skin of domestic animals. In: World Health Organization International Histological Classification of Tumors of Domestic Animals, 2nd series, vol. III. Armed Forces Institute of Pathology, Washington, DC, 1998
14. Gorlin RJ, Barron CN, Chaudhry AP, Clark JJ: The oral and pharyngeal pathology of domestic animals: a study of 487 cases. Am J Vet Res 20:1032-1061, 1959
15. Gorlin RJ, Clark JJ, Chaudhry AP: Oral pathology: the oral pathology of domesticated animals. Oral Surgery 11:500-535, 1958
16. Gyorffy S, Rodriguez-Lecompte JC, Woods JP, Foley R, Kruth S, Liaw PC, Gauldie J: Bone marrow-derived dendritic cell vaccination of dogs with naturally occurring melanoma by using human gp100 antigen. J Vet Intern Med 19:56-63, 2005
17. Hahn KA, DeNicola DB, Richardson RC, Hahn EA: Canine oral malignant melanoma: prognostic utility of an alternative staging system. J Small Anim Pract 35:251-256, 1994
18. Harvey HJ, MacEwen GE, Braun D, Patnaik AK, Withrow SJ, Jongeward S: Prognostic criteria for dogs with oral melanoma. J Am Vet Med Assoc 178:580-582, 1981
19. Head KW: Tumors of the upper alimentary tract. Bull World Health Org 53:145-166, 1976
20. Head KW, Cullen JM, Dubielzig RR, Else RW, Misdorp W, Patnaik AK, Tateyama S, van der Gagg I: Histological classification of tumors of the alimentary system of domestic animals. In: World Health Organization International Histological Classification of Tumors of Domestic Animals, 2nd series, vol. X. Armed Forces Institute of Pathology, Washington, DC, 2003
21. Koenig A, Bianco SR, Fosmire S, Wojcieszyn J, Modiano JF: Expression and significance of p53, Rb, p21/waf-1, p16/qink-4a, and PTEN tumor suppressors in canine melanoma. Vet Pathol 39: 458-472, 2002
22. Laprie C, Abadie J, Amardeilh MF, Net JLLE, Lagadic M, Delverdier M: MIB-1 immunoreactivity correlates with biologic behaviour in canine cutaneous melanoma. Vet Dermatol 12:139-147, 2001
23. Liao JC, Gregor P, Wolchok JD, Orlandi F, Craft D, Leung C, Houghton AN, Bergman PJ: Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma. Cancer Immun 6:8, 2006
24. MacEwen EG, Kurzman ID, Vail DM, Dubielzig RR, Everlith K, Madewell BR, Rodriguez CO Jr, Phillips B, Zwahlen CH, Obradovich J, Rosenthal RC, Fox LE, Rosenberg M, Henry C, Fidel J: Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor. Clin Cancer Res 5:4249-4258, 1999
25. McGill LD, Blue J, Powers B: Report of the ad hoc committee on oncology to the ACVP membership and interested pathology community. Vet Pathol 39:525-528, 2002
26. Mulligan RM: Melanoblastic tumors in the dog. Am J Vet Res 88:345-351, 1961
27. Ramos-Vara JA, Beissenherz ME, Miller MA, Johnson GC, Pace LW, Fard A, Kottler SJ: Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohisto-chemical review of 129 cases. Vet Pathol 37:597-608, 2000
28. Roels S, Tilmant K, Ducatelle R: PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs. J Comp Pathol 21:13-24, 1998
29. Roels S, Tilmant K, Ducatelle R: P53 expression and apoptosis in melanomas of dogs and cats. Res Vet Sci 70:19-25, 2001
30. Schultheiss PC: Histologic features and clinical outcomes of melanomas of lip, haired skin, and nail bed locations of dogs. J Vet Diagn Invest 18:422-425, 2006
31. Smith SH, Goldschmidt MH, McManus PM: A comparative review of melanocytic neoplasms. Vet Pathol 39:651-678, 2002
32. Spangler WL, Kass PH: The histologic and epide-miologic bases for prognostic considerations in canine melanocytic neoplasia. Vet Pathol 43: 136-149, 2006
33. Theon AP, Rodriguez C, Madewell BR: Analysis of prognostic factors and patterns of failure in dogs with malignant oral tumors treated with megavolt-age irradiation. J Am Vet Med Assoc 210:778-784, 1997
34. Todoroff RJ, Brodey RS: Oral and pharyngeal neoplasia in the dog: a retrospective survey of 361 cases. J Am Vet Med Assoc 175:567-571, 1979
35. Weiss E, Frese K: Tumours of the skin. Bull World Health Org 50:79-100, 1974